Westover Capital Advisors LLC Increases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Westover Capital Advisors LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,573 shares of the healthcare conglomerate’s stock after buying an additional 105 shares during the period. UnitedHealth Group comprises 1.3% of Westover Capital Advisors LLC’s portfolio, making the stock its 19th largest holding. Westover Capital Advisors LLC’s holdings in UnitedHealth Group were worth $3,987,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Bray Capital Advisors lifted its holdings in UnitedHealth Group by 0.5% in the 3rd quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after purchasing an additional 50 shares in the last quarter. Innova Wealth Partners boosted its holdings in shares of UnitedHealth Group by 2.9% during the 3rd quarter. Innova Wealth Partners now owns 737 shares of the healthcare conglomerate’s stock valued at $372,000 after purchasing an additional 21 shares during the last quarter. TFC Financial Management Inc. lifted its position in shares of UnitedHealth Group by 7.8% in the third quarter. TFC Financial Management Inc. now owns 417 shares of the healthcare conglomerate’s stock worth $210,000 after buying an additional 30 shares in the last quarter. Rosenbaum Jay D. increased its stake in UnitedHealth Group by 44.6% in the 3rd quarter. Rosenbaum Jay D. now owns 823 shares of the healthcare conglomerate’s stock worth $415,000 after acquiring an additional 254 shares during the last quarter. Finally, Baxter Bros Inc. boosted its position in shares of UnitedHealth Group by 3.9% during the 3rd quarter. Baxter Bros Inc. now owns 1,417 shares of the healthcare conglomerate’s stock valued at $714,000 after acquiring an additional 53 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH traded up $8.40 during trading hours on Thursday, reaching $492.51. 2,169,013 shares of the company traded hands, compared to its average volume of 4,417,949. The stock has a market capitalization of $453.15 billion, a P/E ratio of 29.98, a P/E/G ratio of 1.40 and a beta of 0.55. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The business has a fifty day moving average price of $483.69 and a 200-day moving average price of $513.21. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same period in the previous year, the firm earned $6.26 EPS. The business’s quarterly revenue was up 8.6% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

Analyst Ratings Changes

Several analysts have recently issued reports on UNH shares. TD Cowen decreased their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Bank of America reissued a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Morgan Stanley decreased their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $600.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $570.05.

Insider Activity

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.